News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,706 Results
Type
Article (13638)
Company Profile (108)
Press Release (248960)
Section
Business (87984)
Career Advice (464)
Deals (15333)
Drug Delivery (64)
Drug Development (36556)
Employer Resources (49)
FDA (6267)
Job Trends (6189)
News (150096)
Policy (14013)
Tag
Academia (435)
Alliances (23167)
Alzheimer's disease (370)
Approvals (6275)
Artificial intelligence (72)
Bankruptcy (144)
Best Places to Work (4355)
Breast cancer (63)
Cancer (440)
Cardiovascular disease (45)
Career advice (406)
Cell therapy (60)
Clinical research (30620)
Collaboration (226)
Compensation (95)
COVID-19 (750)
C-suite (73)
Data (445)
Diabetes (64)
Diagnostics (1246)
Drug discovery (45)
Drug pricing (59)
Earnings (31631)
Events (37003)
Executive appointments (253)
FDA (6524)
Funding (150)
Gene therapy (71)
GLP-1 (312)
Government (1271)
Healthcare (3540)
Infectious disease (772)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5843)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3414)
Lung cancer (62)
Manufacturing (112)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9584)
Metabolic disorders (198)
Neuroscience (490)
NextGen: Class of 2025 (1582)
Non-profit (592)
Northern California (541)
Obesity (118)
Opinion (113)
Patents (68)
People (28631)
Pharmaceutical (67)
Phase I (7974)
Phase II (12944)
Phase III (11631)
Pipeline (230)
Policy (47)
Postmarket research (1400)
Preclinical (3180)
Radiopharmaceuticals (116)
Rare diseases (113)
Real estate (2631)
Regulatory (9914)
Research institute (563)
Resumes & cover letters (55)
Southern California (525)
Startups (1625)
United States (5264)
Vaccines (117)
Weight loss (86)
Date
Today (51)
Last 7 days (299)
Last 30 days (788)
Last 365 days (12423)
2025 (518)
2024 (12508)
2023 (14249)
2022 (19556)
2021 (20072)
2020 (19035)
2019 (14889)
2018 (11713)
2017 (13888)
2016 (13130)
2015 (15474)
2014 (12420)
2013 (10593)
2012 (11396)
2011 (11922)
2010 (10889)
Location
Africa (312)
Arizona (45)
Asia (19924)
Australia (2570)
California (1254)
Canada (707)
China (164)
Colorado (50)
Connecticut (54)
Europe (39007)
Florida (207)
Illinois (145)
Indiana (102)
Japan (59)
Kansas (53)
Maryland (184)
Massachusetts (1098)
Minnesota (69)
New Jersey (525)
New York (355)
North Carolina (312)
Northern California (541)
Pennsylvania (336)
South America (500)
Southern California (525)
Texas (167)
Virginia (49)
Washington State (84)
262,706 Results for "altaire pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer
Natera, Inc. today announced the completion of enrollment to the randomized, double-blind phase III ALTAIR clinical trial (JapicCTI-205363/NCT04457297).
July 28, 2023
·
4 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
January 14, 2025
·
6 min read
Policy
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Manufactured and Distributed as Altaire Labeled Products
Altaire Pharmaceuticals, Inc., announces that it is voluntarily recalling the over the counter and prescription drug products and lots, within expiry, it has manufactured and distributed under the Altaire label and trade dress during the time period as indicated below.
July 15, 2019
·
9 min read
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Press Releases
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
November 27, 2024
·
1 min read
Press Releases
Corvus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Apellis Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Press Releases
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
December 31, 2024
·
7 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
1 of 26,271
Next
